High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$47K
$47,681
Total Sells (Filtered)
$20K
$20,072
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
IPSC
S
Century Therapeutics, Inc.
Carr Douglas
• Officer • SVP Finance & Operations
Sell to Cover
2026-03-09
$626
|
||||||
| IPSC |
Century Therapeutics, Inc.
|
Officer • SVP Finance & Operations
Sell to Cover
|
2026-03-09 | $626 | S | Form 4 |
|
IPSC
S
Century Therapeutics, Inc.
Russotti Gregory
• Officer • See Remarks
Sell to Cover
2026-03-09
$1,215
|
||||||
| IPSC |
Century Therapeutics, Inc.
|
Officer • See Remarks
Sell to Cover
|
2026-03-09 | $1,215 | S | Form 4 |
|
IPSC
S
Century Therapeutics, Inc.
Carr Douglas
• Officer • SVP Finance & Operations
Sell to Cover
2026-02-03
$589
|
||||||
| IPSC |
Century Therapeutics, Inc.
|
Officer • SVP Finance & Operations
Sell to Cover
|
2026-02-03 | $589 | S | Form 4 |
| IPSC |
Century Therapeutics, Inc.
|
CEO
Discretionary Buy
|
2025-12-12 | $30,352 | P | Form 4 |
|
IPSC
S
Century Therapeutics, Inc.
Cowan Chad
• Officer • Chief Scientific Officer
Sell to Cover
2025-11-20
$2,736
|
||||||
| IPSC |
Century Therapeutics, Inc.
|
Officer • Chief Scientific Officer
Sell to Cover
|
2025-11-20 | $2,736 | S | Form 4 |
| IPSC |
Century Therapeutics, Inc.
|
CEO
Discretionary Buy
|
2025-11-19 | $17,328 | P | Form 4 |
| IPSC |
Century Therapeutics, Inc.
|
CEO
Sell to Cover
|
2025-11-17 | $14,735 | S | Form 4 |
|
IPSC
S
Century Therapeutics, Inc.
Carr Douglas
• Officer • SVP Finance & Operations
Sell to Cover
2025-11-03
$171
|
||||||
| IPSC |
Century Therapeutics, Inc.
|
Officer • SVP Finance & Operations
Sell to Cover
|
2025-11-03 | $171 | S | Form 4 |